 HOLLISTER, Calif., March 02, 2022 GLOBE NEWSWIRE -- Alpha Teknova, Inc. Teknova Nasdaq: TKNO, a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year 2021 on Tuesday, March 15, 2022, following the close of market. 